Literature DB >> 30599336

Long-term clinical and functional course of borderline personality disorder: A meta-analysis of prospective studies.

Irene Álvarez-Tomás1, José Ruiz2, Georgina Guilera3, Arturo Bados2.   

Abstract

BACKGROUND: This meta-analytic review is the first to synthesise findings from prospective research on the long-term course of borderline personality disorder in adult clinical populations.
METHODS: Systematic searches were conducted in Medline, PsycINFO, PsycArticles, PubMed and Scopus within the period 1990-2017. Inclusion criteria were: (1) adult BPD sample diagnosed by a validated, semi-structured interview; (2) at least two prospective assessments of outcomes; and (3) follow-up period ≥ 5 years. Quality of evidence was rated with the Systematic Assessment of Quality in Observational Research (SAQOR). Four outcomes were meta-analysed using mixed-effect methods: remission from BPD diagnosis, completed suicide, depressive symptoms, and functioning. Potential moderators regarding the natural course and the initial treatment received were studied.
RESULTS: Eleven studies met the inclusion criteria, with 837 participants from nine countries being followed. Between 50% and 70% of the BPD patients achieved remission in the long-term. Significant reductions in depression and functional impairment were also found. Mean suicide rate ranged from 2% to 5%. Younger age was associated with higher likelihood for remission. Being female was correlated with lower functional improvement. Despite some positive trends, there were no significant associations between treatment moderators and the long-term outcome.
CONCLUSIONS: Findings suggest that the course of BPD is characterised by symptomatic amelioration and a slight functional improvement in the long-term. Age and gender modulate the long-term prognosis and should be considered to adapt treatment resources. Further research is required to draw robust conclusions on the long-term effects of psychotherapeutic interventions.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Borderline personality disorder; Course; Follow-up; Long-term; Meta-analysis; Prognosis; Therapy outcome

Mesh:

Year:  2018        PMID: 30599336     DOI: 10.1016/j.eurpsy.2018.10.010

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  8 in total

1.  Non-response to psychotherapy for borderline personality disorder: A systematic review.

Authors:  Jane Woodbridge; Michelle Townsend; Samantha Reis; Saniya Singh; Brin Fs Grenyer
Journal:  Aust N Z J Psychiatry       Date:  2021-09-15       Impact factor: 5.598

2.  Functional Impairment in Borderline Personality Disorder: The Mediating Role of Perceived Social Support.

Authors:  Beatriz Thadani; Ana M Pérez-García; José Bermúdez
Journal:  Front Psychol       Date:  2022-05-27

3.  Sex, Gender, and Suicidal Behavior.

Authors:  Maria Luisa Barrigon; Fanny Cegla-Schvartzman
Journal:  Curr Top Behav Neurosci       Date:  2020

Review 4.  Diagnosis and Treatment of Borderline Personality Disorder in Young People.

Authors:  Andrew M Chanen; Katie Nicol; Jennifer K Betts; Katherine N Thompson
Journal:  Curr Psychiatry Rep       Date:  2020-04-25       Impact factor: 5.285

5.  Commenting and connecting: A thematic analysis of responses to YouTube vlogs about borderline personality disorder.

Authors:  Clare M King; Darragh McCashin
Journal:  Internet Interv       Date:  2022-04-17

6.  Real-World Functioning in Psychiatric Outpatients: Predictive Factors.

Authors:  Paola Bozzatello; Benedetta Giordano; Cristiana Montemagni; Paola Rocca; Silvio Bellino
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

Review 7.  Specialist teams as constituted are unsatisfactory for treating people with personality disorders.

Authors:  Conor Duggan; Peter Tyrer
Journal:  BJPsych Bull       Date:  2022-04

8.  The course of (comorbid) trauma-related, dissociative and personality disorders: two year follow up of the Friesland study cohort.

Authors:  Sanne Swart; Marleen Wildschut; Nel Draijer; Willemien Langeland; Adriaan W Hoogendoorn; Jan H Smit
Journal:  Eur J Psychotraumatol       Date:  2020-05-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.